Tim Piotrkowski

and are prescribed, so things like GHK-CU, BPC-157, of course, TB-500.

I mean, a lot of the let's let's use BPC 157 as the example.

A lot of these substances don't have that level of evidence.

And even for BPC, I wouldn't say that it was fantastic.

Lots of preclinical stuff.

And there's three human studies to date that were very, very much pilot studies.

I guess outside of that, no, people are relying on animal studies with rodents usually.

That said, I just do want to make a point that a lot of people, and perhaps this does relate to the placebo effect,

A lot of people do order these and do express positive stories about how it's relieved their pain or they're feeling better or whatever else.

And I think we'd be foolish to discount that completely and really just points to the fact that we need to gather the resources and interrogate this with robust research.

So they actually had to bring them in to the service because sending them in the mail is illegal.

But when they came in and dropped them off, we then had to cart them off for an analysis.

We found that across two years of roid check, which is what the program was called, that less than one in 10 of the steroids submitted were the right steroid and the right dose of a subset that we tested.

We found toxic heavy metals outside of permissible daily limits in almost all of those.

So things like arsenic, lead and cadmium.

So currently have a trial underway where we have people submitting and we are testing those results.

I wish I could tell you, but I don't know yet.

I'm waiting.

We're waiting to see.

I do have a feeling that if this is the same unregulated enhancement drug market as steroids.